Table 1. Characteristics of study patients.

No.	Gender	Age	Diagnosis	Metastatic tumor	Recurrence	primary	Protocol
1	M	26	Osteosarcoma	Lumbar, lung	+	Tibia	Basic
2	M	15	Osteosarcoma	Lung	+	Tibia	Basic
3	F	9	Osteosarcoma	Lung, lumbar	–	Femur	Basic
4	M	31	Chondrosarcoma	Lung	–	Tibia	Basic
5	F	53	Leiomyosarcoma	Lung	+	Inguen	Basic
6	F	19	Osteosarcoma	Lung	–	Femur	Basic
7	F	17	Osteosarcoma	Pelvis, humerus, lumbar, lung	–	Femur	Basic
8	F	49	Osteosarcoma	Lung, tibia, brain	–	Femur	Basic
9	F	61	Clear cell sarcoma	–	+	Foot	Basic
10	F	40	ASPS	Lung	–	Hand	Basic
11	M	65	Leiomyosarcoma	–	+	Thigh	Basic
12	M	24	Osteosarcoma	Lung	–	Femur	Basic
13	M	45	Osteosarcoma	Lung, femur	+	Pelvis	Basic
14	M	19	Osteosarcoma	Lung, brain	–	Femur	Basic
15	M	59	MFH	Lung	+	Tibia	Basic
16	M	29	Angiosarcoma	Lung	–	Lower leg	Basic
17	M	43	Chondrosarcoma	Lung, calcaneus	–	Tibia	Basic
18	F	43	Clear cell sarcoma	Lung	–	Lower leg	Basic
19	F	26	Clear cell sarcoma	Thigh, inguen	–	Lower leg	Basic
20	M	59	Synovial sarcoma	lung	–	Lower leg	Basic
21	M	30	Osteosarcoma	Lung	–	Femur	Basic
22	F	39	Chondrosarcoma	–	+	Pelvis	Modified
23	M	37	Liposarcoma	Lung	–	Thigh	Modified
24	F	27	Osteosarcoma	Lung	–	Pelvis	Modified
25	F	41	Synovial sarcoma	Lung	–	Back	Modified
26	F	24	Synovial sarcoma	Lung	–	Inguen	Modified
27	M	64	MFH	–	+	Back	Modified
28	F	8	Ewing's sarcoma	Lung	–	Calf	Modified
29	M	31	Osteosarcoma	Lung	–	Femur	Modified
30	F	64	MFH	Lung	–	Shoulder	Modified
31	F	28	Osteosarcoma	Lung	–	Pelvis	Modified

Protocol: DC-preparation protocol; MFH, malignant fibrous histiocytom; ASPS, alveolar soft part sarcoma; MPNST, malignant peripheral nerve sheath tumor.